MINIject is iSTAR Medical’s innovative minimally invasive glaucoma surgery (MIGS) device for patients with open-angle glaucoma. Targeting the supraciliary space, it delivers meaningful, and sustained control of intraocular pressure (IOP).
The MINIject implant is made of proprietary Star material; a soft and flexible, medical-grade silicone. It has anti-fibrotic properties through its micro-pores, which enable bio-integration and a natural flow of fluid throughout the implant. Three-year follow-up results presented at the 2023 World Glaucoma Congress demonstrate sustained, meaningful, mean IOP reduction of 36%, with 42% of patients medication-free. Mean endothelial cell density loss at three years was 9% (less than for cataract surgery at two years).1
Contact: istar-medical.com
